HL
Therapeutic Areas
Bioventus Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DUROLANE | Knee Osteoarthritis | Commercial |
| StimRouter | Chronic Peripheral Nerve Pain | Commercial |
| EXOGEN Bone Healing System | Fracture Healing & Nonunions | Commercial |
| SonicOne O.R. / SonaStar | Hard & Soft Tissue Surgical Removal | Commercial |
| OsteoAMP / AlloFuse | Bone Grafting | Commercial |
| Investigator Initiated Studies (IIS) | Various (Pain, Bone Healing) | Research |
Leadership Team at Bioventus
RC
Robert Claypoole
Chief Executive Officer
MS
Mark Singleton
Senior Vice President and Chief Financial Officer
KC
Katrina Church
Chief Compliance Officer
AD
Anthony D’Adamio
Senior Vice President and General Counsel
MC
Mike Crowe
Senior Vice President, Operations
DV
Dave Venner
Senior Vice President, General Manager, Surgical
KS
Kellie Stefaniak
Vice President of Global Regulatory and Quality
AD
Anthony Doyle
General Manager, Pain Treatment & Restorative Therapies
SB
Sharath Bhat
Vice President/General Manager, EMEA APAC
WA
William A. “Bill” Hawkins III
Chairman of the Board